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ABSTRACT
Ataxia telangiectasia is a rare, multi system disease caused by ATM
kinase deficiency. Atm-knockout mice recapitulate premature aging,
immunodeficiency, cancer predisposition, growth retardation and
motor defects, but not cerebellar neurodegeneration and ataxia. We
explored whether Atm loss is responsible for skeletal muscle defects
by investigating myofiber morphology, oxidative/glycolytic activity,
myocyte ultrastructural architecture and neuromuscular junctions.
Atm-knockout mice showed reduced muscle and fiber size. Atrophy,
protein synthesis impairment and a switch from glycolytic to oxidative
fibers were detected, along with an increase of in expression of slow
and fast myosin types (Myh7, and Myh2 and Myh4, respectively)
in tibialis anterior and solei muscles isolated from Atm-knockout
mice. Transmission electron microscopy of tibialis anterior revealed
misalignments of Z-lines and sarcomeres and mitochondria
abnormalities that were associated with an increase in reactive
oxygen species. Moreover, neuromuscular junctions appeared larger
and more complex than those in Atm wild-type mice, but with
preserved presynaptic terminals. In conclusion, we report for the first
time that Atm-knockout mice have clear morphological skeletal
muscle defects that will be relevant for the investigation of the
oxidative stress response, motor alteration and the interplay with
peripheral nervous system in ataxia telangiectasia.
KEY WORDS: Atm, Skeletal muscle, ROS, Atrophy, Slow myosin,
Myopathy
INTRODUCTION
Ataxia telangiectasia (A-T) is a rare genetic disorder caused by
mutations in ATM gene that cause ATM kinase instability and loss
of function (Uziel et al., 1996). In humans, A-T is characterized
by progressive ataxia, neurodegeneration, premature aging,
immunodeficiency and cancer predisposition that ultimately leads
to death within the fourth decade of life (Gatti et al., 1988; Micol
et al., 2011). Pathoanatomical studies show degeneration of
cerebellar Purkinje cells as the prominent hallmark of the disease,
although some studies suggest concomitant alteration of
extracerebellar structures, such as the brainstem and basal ganglia
(Hoche et al., 2012; Kieslich et al., 2010; Lavin et al., 2007). As a
consequence of cerebellar defects, patients may show several
secondary abnormalities in eye movement, breathing and fine motor
skill control (Hoche et al., 2012; Kieslich et al., 2010). Many
patients also exhibit somatic growth retardation and growth factor
deficiency (Hoche et al., 2012; Schubert et al., 2005; Voss et al.,
2014). In particular, central cerebral white matter affection, spinal
atrophy and extrapyramidal symptoms are more often observed in
patients with pronounced deficiency of the growth hormone/insulin-
like growth factor 1 (GH/IGF-1) axis and with markedly reduced
body weight and high ataxia scores (Hoche et al., 2012; Schubert
et al., 2005; Voss et al., 2014). Atm-null mice recapitulate most of
the characteristics of A-T patients, including extreme radiosensitivity,
immune system deficiency, germ cell defects and cancer
predisposition (Barlow et al., 1996; Elson et al., 1996; Xu et al.,
1996). Like A-T patients, mice homozygous for Atm disruption are
smaller in size than Atm wild-type and heterozygous mice (Barlow
et al., 1996; Di Siena et al., 2018). The body size difference is already
present at birth and becomes more evident throughout the growing
period, indicating a direct effect of Atm lack on cellular growth. Mice
homozygous for the disruption of Atm gene also show defects in
exercise performance such as rota-rod, open-field and hind-paw
footprint motor function abnormalities; however, they do not exhibit
histological brain abnormalities, including cerebellar architecture
defects and Purkinje cell degeneration (Barlow et al., 1996; Browne
et al., 2004; Reliene et al., 2008).
ATM protein is a key player in cell cycle checkpoint control and
DNA repair after DNA double-strand breaks (DSBs) caused by
endogenous sources, ionizing radiation (IR) or oxidative damage
(Ditch and Paull, 2012; Shiloh, 2014). More recently, increasing
evidence has demonstrated that ATM plays critical functions in
protein synthesis and degradation (Santini et al., 2014; Yang and
Kastan, 2000), mitochondria ATP generation, reactive oxygen
species (ROS) production and cellular respiration (Ambrose et al.,
2007; Valentin-Vega et al., 2012).
Recent works in skeletal muscle-derived cells and soleus muscle
have demonstrated that cytoplasmic ATM is involved in the insulin/
IGF-1 signaling cascade by phosphorylating Akt family proteins
(Andrisse et al., 2013; Ching et al., 2013; Jeong et al., 2010).
However, to our knowledge, no information has been reported on
the role of ATM in skeletal muscle structure and function.
Based on the current data, we hypothesized that the absence of
central nervous system neurodegeneration inAtm-knockout (Atm−/− )
mice could allow the specific investigation of potential primary
skeletal muscle and peripheral nervous system defects.
Here, we show, for the first time, a defective skeletal muscle
phenotype in Atm−/−mice. The lack of Atm was sufficient to induce
severe muscle wasting and atrophy associated with significant
alteration of sarcomere organization, and significant changes in
mitochondria number, morphology and ROS production. AnalysisReceived 20 July 2018; Accepted 22 January 2019
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of phosphoinositide 3-kinase (PI3K)/Akt signaling cascade
revealed activation of several atrophy-related genes, inhibition of
autophagic pathways and reduction of protein synthesis complex.
Metabolic assay showed a switch to oxidative fibers, and
biochemical and molecular analyses highlighted an increase of the
myosin structural component of the skeletal muscle. Neuromuscular
junctions were also affected in Atm−/− mice, according to
morphological and molecular investigations. In summary, we
show that the Atm−/− model is valuable to study the impact of
Atm in skeletal muscle homeostasis and to investigate the
intracellular signal perturbations following Atm impairment.
RESULTS
Atm−/− mice exhibit reduced muscle mass and fiber size
Atm−/− males and females show smaller size and reduced body
weight compared to Atm+/+ mice (Barlow et al., 1996; Di Siena
et al., 2018; Elson et al., 1996) (Fig. 1A,B). We isolated and
weighed individual muscles from males, such as the slow twitch
soleus, the mixed tibialis anterior and the mixed quadriceps. All the
muscles dissected from Atm−/− males showed a significant mass
reduction compared to those from Atm+/+ mice (Fig. 1C). We next
evaluated the consequence of Atm deficiency by H&E staining of
sections from soleus (Fig. 1D). The number of fibers was similar in
solei of Atm+/+ and Atm−/− mice (Fig. 1E). Although no necrotic
and degenerating fibers were found in Atm−/− mice, myofibers
appeared extremely small compared to those in Atm+/+ controls
(Fig. 1D). Quantification of fiber area reveals that there was an
increased number of hypotrophic fibers in Atm−/− solei [Fig. 1F;
mean cross sectional area (CSA) values: Atm+/+, 1153.27±93.65;
Atm−/−, 477.55±129.33].
Collectively, these data indicate that absence of Atm kinase
severely affects muscle mass, primarily by decreasing myofiber
size.
Increase of muscle atrophy in Atm−/− tibialis anterior
Expression of atrophy-related genes was then investigated. The most
critical players in muscle atrophy are the transcription factors of
the forkhead box O (FoxO) family (Sandri et al., 2004). The
dephosphorylation/activation of FoxO3 leads to upregulation of
MAFbx (also known as Atrogin1 or FBXO32) and MuRF1 (also
known as TRIM63), which represent molecular targets of FoxO
activity (Sandri et al., 2004; Schiaffino et al., 2013). Western blot
analysis revealed a selective downregulation of the phosphorylated
form of FoxO3 in Atm−/− compared to Atm+/+ mice (Fig. 2A). This
was accompanied by autophagy inhibition, as measured by the
decrease in the ratio of LC3-II:LC3-I (Fig. 2A), which has been
reported to cause muscle atrophy (Mammucari et al., 2007).
Quantitative RT-PCR (qRT-PCR) analysis revealed that both
MuRF1 and Atrogin1 expression is increased in Atm−/− compared
to Atm+/+ mice (Fig. 2B). Taken together, these results indicate that
Atm is indispensable for skeletal muscle integrity by inducing
autophagic pathways and inhibiting atrophy-related genes.
Impairment of Akt pathway and protein synthesis in Atm−/−
tibialis anterior
Muscle atrophy might be related to an increase of protein
degradation through activation of the proteasome–ubiquitin
pathway (Bilodeau et al., 2016; Santini et al., 2014) and/or to
defects in protein synthesis (Yang and Kastan, 2000).
We initially analyzed the ubiquitin–proteasome pathway in
protein extracts derived from tibialis anterior muscles. Western
blot analysis revealed that total protein ubiquitylation is not
significantly increased in Atm−/− compared to Atm+/+ tibialis
anterior muscle (data not shown).
A-T patients show reduced IGF-1 serum level, and decreased Akt
phosphorylation has been observed in several ATM-deficient
systems indicating a compromised IGF-1–PI3K–Akt axis and
defective protein synthesis process in the absence of ATM. In order
to study whether an impairment of Akt pathway could be correlated
with muscle wasting in Atm−/− mice, protein extracts from tibialis
anterior of wild-type and knockout mice were analyzed for
phosphorylation of Akt family proteins and for the activation state
of translation complexes (Fig. 3). Akt phosphorylation was strongly
reduced in tibialis from Atm−/− mice and also the phosphorylated
form of its target GSK3β (Fig. 3A,B). Notably, a decreased
phosphorylation was observed for the cap-binding factor eIF4E and
for the eIF4E-binding protein, 4E-BP1 (also known as EIF4EBP1)
(Fig. 3A,B). These results suggest that Atm is indispensable for
skeletal muscle protein synthesis through the PI3K/Akt pathway.
Increased numberof oxidativemyofibers andupregulation of
slow myosin in Atm−/−mice
To investigate whether fiber atrophy was associated to a metabolic
alteration, we performed NADH-tetrazolium reductase (NADH-
TR) staining on frozen sections of tibialis anterior. Atm−/− muscles
displayed increased prevalence of oxidative fibers at the expense of
glycolytic fibers, which display decreased numbers (Fig. 4A). Since
abundance of oxidative fibers is typically associated with type I
fiber predominance, the levels of myosin heavy chain (MyHC) of
the slow type was assayed by immunofluorescence staining. Slow
MyHC is barely expressed in Atm+/+ tibialis anterior; however, a
strong increase of the myosin was detected in Atm−/− tibialis
(Fig. 4B). These results were confirmed by western blot analysis
(Fig. 4C), which showed that also total MyHC protein levels were
increased in Atm−/−, suggesting a global upregulation of myosin
isoforms. A detailed analysis of myosin transcripts revealed that
both mRNAs for slow MyHC1 (encoded by Myh7) and those of
the fast type, MyHC2A and MyHC2B (encoded by Myh2 and
Myh4) were significantly increased in Atm−/− compared to Atm+/+
soleus muscle (Fig. 4D).
Collectively, these data suggest increased oxidative fiber
abundance in the absence of Atm, with a significant fast-to-slow
fiber-type switching.
Abnormal muscle architecture and elevated mitochondrial
ROS production in Atm−/−muscle
Tibialis anterior of Atm+/+ and Atm−/− mice was analyzed at
ultrastructural level by transmission electron microscopy (TEM)
(Fig. 5).We observed several morphological abnormalities inAtm−/−
muscles. The most evident alterations were the increased number and
size of coupled mitochondria present at the Z-lines in the muscle of
Atm−/− (Fig. 5E,I) compared to Atm+/+ (Fig. 5A,I) mice. In several
cases, mitochondria were clustered in longitudinal rows between
myofibrils, appearing abnormally shaped and sized (Fig. 5E) and,
rarely, swollen (Fig. 5F,G) inAtm−/− (Fig. 5F,G) compared toAtm+/+
tibialis (Fig. 5B,C).
Myofibrillar architecture appeared normal, although sarcomeres
were often out of register in Atm−/− (Fig. 5E, black asterisks)
compared to Atm+/+ tibialis (Fig. 5A). Sarcomeric units were found
in overabundance, with shorter Z-lines in Atm−/− (Fig. 5E,I)
compared to Atm+/+ (Fig. 5A,I) mice, despite their similarity in
length (Fig. 5I). No abnormalities were noted in triad structure
(Fig. 5C,G), which were normally flanking each Z-line at the
myofibril border. These data indicate that Atm−/− skeletal muscles
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present ultrastructural defects both in the contractility machinery
and in the organelles that produce cellular energy, suggesting an
increase of ROS and a defective oxidative stress response in Atm−/−
muscles. For this reason, mitochondrial superoxide production was
evaluated by MitoSOX Red fluorogenic dye in freshly isolated
tibialis anterior muscles (Fig. 6) of Atm+/+ and Atm−/− mice. As
Fig. 1. Morphometry of skeletal muscles in Atm−/−mice. (A) Representative images of 2-month-old males showing the reduced size of Atm−/−mice. (B) Body
weight and tibia length are reported for 2-month-old Atm+/+ and Atm−/− mice. n=10 mice/genotype. ***P<0.001. (C) Representative image of tibialis anterior,
soleus and quadriceps muscles and relative weight from 2-month-old Atm+/+ and Atm−/− mice. n=7 mice/genotype. Scale bars: 0.5 cm. **P<0.01; ***P<0.001.
The box represents the 25–75th percentiles, and the median is indicated. The whiskers show the minimum and maximum values. (D) H&E staining of a soleus
section from Atm+/+ and Atm−/− mice. Scale bars: 50 µm. Magnification of fibers and nuclei are shown in the insets. (E) Count of fiber number in solei of Atm+/+
and Atm−/− mice. The mean±s.e.m. value is reported. n=3 mice/genotype. (F) Frequency distribution of soleus fiber size from n=2 mice for each genotype.
The CSA of most soleus fibers ranged between 100 and 400 µm2 in Atm−/− mice.
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shown in Fig. 6A,B, the relative fluorescence intensity of MitoSOX
Red in muscle fibers of Atm−/− mice is significantly higher when
compared to Atm+/+ muscle fibers.
Neuromuscular junction defects in Atm−/−muscle
The ability to form and maintain synapses is a fundamental property
of the mammalian nervous system required to generate functional
neuromuscular connection and to establish a network connectivity.
The size, shape and complexity of synapses were evaluated in
quadriceps of Atm+/+ and Atm−/− mice by staining with α-
bungarotoxin and PGP 9.5 or synaptophysin 1 to monitor the
muscular and nervous counterparts of the neuromuscular junction,
respectively (Chen et al., 2010) (Fig. 7A,C and data not shown).
Analyses of α-bungarotoxin immunofluorescence (Fig. 7A)
revealed no alteration in the number of neuromuscular junctions
(NMJs) in Atm−/− compared to Atm+/+ mice (Fig. 7B), while the
area of NMJs was increased, as well as the total length and average
number of NMJ branches (Fig. 7A,B) in Atm−/−muscles. We found
that the number of secondary branches was increased in Atm−/−
tibialis anterior and both primary and secondary branches
showed increased length (Fig. 7A,B). Overlapping staining of
α-bungarotoxin and PGP 9.5 or synaptophysin 1 of NMJ suggests
muscle-specific defects without synaptic transmission impairment
in Atm−/− mice (Fig. 7C and data not shown). We further
investigated the expression of the α7 neuronal nicotinic
acetylcholine receptor subunit and myogenin, the transcription
factor promoting acetylcholine receptor gene transcription. An
increase of the receptor and its regulator was observed in solei from
Atm−/−mice compared to Atm+/+mice (Fig. 7D,E). Taken together,
these results indicate that the complexity of NMJ is increased in
Atm−/− mice, possibly reflecting the switch to oxidative fibers.
DISCUSSION
Mutations in the human ATM gene, located on the long arm of
chromosome 11 (q22–23), cause A-T, a highly pleiotropic autosomal
recessive disorder (Platzer et al., 1997; Savitsky et al., 1995). A-T
patients exhibit hematologicmalignancy, neurodegeneration, sterility
and radiosensitivity (Lavin and Shiloh, 1997). A-T patients are also
characterized by growth retardation, heart problems, tremors and
several difficulties in movements; however, it is not possible to
distinguish whether muscle defects are secondary to the cerebellar
defects or primary to muscle fibers. Here, we report a novel
Fig. 2. Molecular signature of atrophy
increases and autophagy decreases in
Atm−/− skeletal muscles. (A) Representative
western blot for a marker of atrophy (FoxO3a)
and of autophagy (LC3) as revealed in
proteins extracted from tibialis anterior muscle
of Atm+/+ and Atm−/− mice. Densitometric
quantification shows a decrease of FoxO3a
phosphorylation (pFoxO3) and a decrease of
LC3-II:LC3-I ratio in Atm−/− compared to
Atm+/+ tibialis anterior muscles. Dot plots of
individual data points and mean±s.e.m. values
are shown. FoxO3a and tubulin were used as
loading control. n=4 mice/genotype. *P<0.05;
***P<0.001. (B) qRT-PCR analysis of the
FoxO3 targets Atrogin1 andMuRF1 confirming
the activation of atrophic pathways in Atm−/−
skeletal muscles. Gapdh was used as a
housekeeping gene. Data were obtained from
triplicates of n=3 mice/genotype. *P<0.05.
The mean±s.e.m. values are reported.
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phenotype of Atm−/−mice related to severe skeletal muscle defects at
structural and signaling levels that might impair muscle functionality.
Despite neuromotor defects and neurological abnormalities,
Atm−/− mice do not develop central nervous system defects and
do not manifest neurodegeneration, presumably because they die
early (Barlow et al., 1996; Elson et al., 1996; Kuljis et al., 1997). For
these reasons, the Atm−/− model allows study of primary skeletal
muscle and neuromuscular junction defects. Our analysis revealed
that almost 80% of male mice showed reduced body weight; in
addition, various skeletal muscles analyzed showed that they were
smaller in size compared to those in wild-type litters. Further
analysis in soleus muscles showed that fiber number was unaltered
but cross sectional area was reduced more than 2-fold in Atm−/−
mice. In A-T patients, GH/IGF-1 blood serum levels are often
reduced (Kieslich et al., 2010), partially explaining patient body
weight reduction. Given the high variability among mice, we did not
obtain conclusive results on Igf1 transcript levels in soleus muscle
from Atm−/−. Nevertheless, a clear inhibition of the PI3K/Akt
pathway was observed in tibialis anterior muscles, consistent with
previous reports describing that Atm kinase is crucial for Akt
phosphorylation and protein translation (Jeong et al., 2010; Yang
and Kastan, 2000). Moreover, genes related to atrophy were
upregulated through FoxO3a-mediated protein de-phosphorylation.
The autophagic pathway, as monitored by the ratio between the two
LC3 forms that are differently phospholipidated, was reduced in
Atm−/− muscles as was previously reported in the absence of its
kinase activity (Santini et al., 2014), suggesting a defect in the
turnover of muscle fibers in this mouse model and supporting the
normal number of fibers observed in muscles.
Investigation of the myosin component revealed an increase of
slow myosin that correlated with a switch to slow-twitched fibers in
Atm−/− muscle. However, an increase of MyHC2A and MyHC2B
was also observed, contributing to the amount of total myosin
detected by western blot. A possible explanation of total myosin
protein upregulation and fiber atrophy is the increase of sarcomere
number, as observed at the electron microscopy, in Atm−/−
Fig. 3. Protein synthesis impairment
in muscles from Atm−/− mice.
(A) Representative western blot of the
protein targets downstream of Atm kinase.
Phosphorylated Akt (pAkt), phosphorylated
GSK3β (pGSK3β), phosphorylated eIF4E
(peIF4E) and 4E-BP1 were monitored in
extract from tibialis anterior muscle of Atm+/+
and Atm−/− mice. (B) Relative densitometric
analysis of phosphorylated versus non-
phosphorylated protein is reported as mean
±s.e.m value of n=4 mice/genotype. Dot plots
of individual data points are shown. *P<0.05,
**P<0.01.
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compared to Atm+/+ muscle. This result might suggest that more
contraction modules and, consequently more myosin molecules,
are required in Atm−/− muscles, possibly due to functional
compensatory effects. The most notable alteration observed in
the ultrastructural organization of Atm−/− muscle fibers was the
enlargement of coupled mitochondria, their higher number and the
presence of giant mitochondria that might be correlated to premature
aging of Atm−/− mouse models. Mitochondrial morphological
alterations were previously observed in thymocytes from Atm−/−
mice (Valentin-Vega et al., 2012) and they were related to an
increase of ROS levels, a reduction in ATP production and oxidative
complex I deficiency in these cells (Stagni et al., 2018; Valentin-
Vega et al., 2012). Indeed, evaluation of ROS revealed increased
levels of superoxide in the mitochondria of live fibers of Atm−/−
Fig. 4. Atm−/− mice exhibited increased numbers of oxidative myofibers and induction of myosin isoform expression. (A) NADH-TR staining of
tibialis anterior muscle sections. Quantitative analysis was performed in tibialis anterior sections from n=4 mice/genotype. Scale bar: 100 µm. Fibers were
classified as glycolytic (Gly., white), intermediate (Int., light blue) or oxidative (Ox., dark blue) based on staining intensity. (B) Representative immunofluorescence
staining of slow MyHC (green) in tibialis anterior muscle of Atm+/+ and Atm−/−. The sarcolemma is visible by the unspecific staining of anti-slow MyHC
antibody. Nuclei were stained with DAPI. Scale bar: 100 µm. (C) Representative western blot analysis of protein extracts obtained from tibialis anterior
muscles. Slow and total MyHC increased in the Atm−/− muscles. Tubulin was used as loading control. Data were obtained from n=4 mice/genotype of each
genotype. (D) qRT-PCR analysis of MyHC1 (Myh7), and MyHC2A and MyHC2B (Myh2 andMyh4) isoforms.Gapdhwas used as housekeeping gene. Data were
obtained from triplicates of n=4 mice/genotype. *P<0.05, **P<0.01. The mean±s.e.m. values are reported in A and D.
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mice compared to the age matched wild-type controls, implying that
ATM could guarantee muscle integrity.
To understand whether ultrastructural alteration would be
reflected in periphery nervous system defects, we analyzed
neuromuscular junctions, because they represent a functional
bridge between the muscle and nervous compartments. Increase
of α7 nicotinic acetylcholine receptor levels and increase of NMJ
surface area and complexity of branching implicate dysfunctional
plaques in Atm−/− muscles, and correlate with type fiber switching
and aging in Atm−/−mice. Nevertheless, no alteration was evident in
terminal nerves as evaluated by synapse and synaptic vesicles
marker staining. Indeed, recent works have demonstrated that
muscle-specific defects influence NMJ integrity despite preserved
central nervous system (Dobrowolny et al., 2018, 2008).
Overall, considering the latest and previous defects together with
the heart skeletal muscle problems reported in humans, we might
hypothesize alteration in muscle contraction and function in the
absence of ATM. In the future, we will address the functionality of
skeletal muscle fibers isolated from Atm−/− mice in physiological
conditions and after skeletal muscle damage.
In summary, these results clearly indicate that Atm−/− mouse
model shows skeletal muscles defects at the tissue, cellular and
Fig. 5. Abnormal myofibrillar architecture in the absence of Atm. (A–H) TEM micrographs of tibialis anterior muscle from Atm+/+ and Atm−/− mice.
Control mice exhibited normal myofibrillar architecture (A,D). Atm−/− compared to Atm+/+ muscles showed an increased number of sarcomeres per area
unit (A versus E,I), shorter Z-lines (A versus E,I), and an increased number and diameter of coupled mitochondria. Giant mitochondria (A versus E), swollen
andwith disorganized cristae (B,D versus F,H) were also observed. Asterisks indicate out of register Z-lines. The black arrowhead indicates a giant mitochondrion.
Data were obtained from n=3 mice/genotype. Different magnifications are shown and scale bar sizes are indicated.
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ultrastructural levels. The muscle phenotype of Atm−/−mice is more
relevant if considering that most of A-T patients die because of
defects in diaphragm contraction and respiratory failure. In this
context, our data showing that Atm−/−mice manifest skeletal muscle
defects provide support for multisystem therapeutic interventions
restoring ATM function in nervous and skeletal muscle ATM-
deficient cells and promote future studies into the role of ATM in
oxidative stress, atrophy and aging.
MATERIALS AND METHODS
Mice
Atm+/− mice, previously generated (Barlow et al., 1996), were kindly
provided by Andre Nussenzweig (National Institutes of Health, Baltimore,
MD). For experimental analysis were used males of 2 months of age in
129/SvEv×C57BL/6J background, obtained from the following breeding:
Atm+/−×Atm+/−.
The following primers were used for genotyping: Atm-F, 5′-GACTTC-
TGTCAGATGTTGCTGCC-3′; Atm-R, 5′-CGAATTGCAGGAGTTGCT-
GAG-3′; Atm-Neo, 5′-GGGTGGGATTAGATAAATGCCTG-3′ Atm-F/R
identifies the wild-type allele (200 bp) and Atm-F/Neo identifies the null
allele (400 bp).
The health status of the treated mice was monitored twice a week. Mice
were housed at the animal facility of Tor Vergata University, under standard
conditions with free access to food diet and water. All animal studies were
performed in accordance with the Guidelines for the Care and Use of
Laboratory Animals and protocols were approved by the Tor Vergata
Animal Care, Ethics Committee and the Italian Ministry of Health (protocol
no. 1104/2016-PR, art. 31 of D.lgs 24/2014).
Tissue isolation
Mice were weighed in a technical scale (VWR, Science Education). After
cervical dislocation, muscles were immediately dissected and weighed in
pairs using an analytical scale (Ohaus Pioneer). For mRNA and protein
extraction, tissues were snap-frozen in cold-ice and stored at −80°C. For
hematoxylin and eosin (H&E) staining, tissuewas fixed overnight in formalin
(Sigma). For immunofluorescence and NADH-TR staining, muscles were
snap-frozen in liquid-nitrogen-cooled isopentane and stored at −80°C until
cryosectioning. For neuromuscular junction detection, quadriceps were
embedded in OCT (Bio-Optica), snap-frozen in liquid-nitrogen-cooled
isopentane and stored at −80°C until preparation of cryosections.
Skeletal muscle histological analysis, CSA measurement and
immunofluorescence
Immediately after animals were euthanized, the two gastrocnemius, soleus
and tibialis anterior muscles, were dissected and weighed. Tibialis and
soleus were used to perform the molecular and histological analysis.
Muscles used for histology were immediately fixed in 10% phosphate-
buffered formalin and embedded in paraffin. The morphological changes
were measured by H&E staining of 5 μM sections following standard
procedures. Myofiber cross sectional area (CSA) measurement was
performed on paraffin-embedded soleus from Atm+/+ and Atm−/− mice.
Fig. 6. Increased ROS levels in live tibialis
anterior muscles of Atm−/− mice.
(A) Representative maximum intensity projections
of live Atm+/+ and Atm−/− fibers stained with
MitoSOX Red (left panels, red) and relative bright
field (right panels, BF). White asterisks indicate
unspecific staining of cell nuclei. (B) Fluorescence
intensity analysis of MitoSOX Red labeling in Atm+/+
andAtm−/−mice is measured in voxel units. Data are
mean±s.e.m. obtained from n=3 mice/genotype.
*P<0.05.
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Fig. 7. See next page for legend.
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Fifty serial muscle sections (8 μm) from the mid-portion to the distal-portion
of each soleus were obtained and stained with H&E. Bright-field images
were taken by using an Axioskop microscope (Carl Zeiss) and 10 fibers for
each section were randomly selected and measured by using ImageJ
software (version 1.49). For each slice, all the fibers were counted.
NADH-TR staining (Nitrotetrazolium Blue Chloride, N6876 and N6639,
Sigma) was performed according to the manufacturer’s protocol. Briefly,
the oxidative reaction was conducted in 8 µm tibialis anterior cryosections
incubated for 35 min at room temperature, washed with deionized water and
mounted with Eukitt (ElectronMicroscopy Sciences). Images were acquired
with an inverted microscope (Axiovert 200M; Carl Zeiss, Inc., Thornwood,
NY). The number of oxidative, glycolytic and intermediate fibers was
evaluated in three sections of n=4 mice/group.
Immunofluorescence staining was performed using standard protocols.
After permeabilization and blocking with 1% BSA, samples were incubated
with mouse anti-myosin, skeletal, slow (1:400, Sigma, #M8421) and diluted
in 0.5% BSA overnight at 4°C. Secondary antibody anti-mouse-IgG
conjugated to Alexa Fluor 488 was diluted 1:400. Images were acquired by
Nikon Eclipse Ti-S microscope (Nikon Instruments, Nikon Instruments
S.p.A, Firenze, Italy). DAPI was used to counterstain nuclei.
For NMJ staining, segments of quadriceps from Atm+/+ and Atm−/−mice
were embedded in OCT and snap-frozen in nitrogen-cooled isopentane.
Longitudinal frozen sections (40 μm) were fixed in paraformaldehyde 4%
for 10 min and stained with polyclonal rabbit anti-PGP 9.5 (1:200, Dako,
Z5116) or mouse anti-synaptophysin 1 antibody (1:50, Synaptic Systems,
101011) diluted in PBS with 3% BSA/5% donkey serum/0.05% Tween 20
overnight at 4°C and with α-bungarotoxin, Alexa Fluor 488 conjugate
(1:1000, Invitrogen) at RT for 1 h. Alexa Fluor 555 (1:500) was used as
secondary antibody. Slides were mounted with buffered glycerol 60%
and confocal images were taken using an Olympus FV1200 laser scanning
confocal microscope and analyzed with Olympus FluoView software.
Images of at least 30 NMJ were taken for each group; the z-stacked
fluorescence images (2 μm per focal plane) were collected and
analyzed using ImageJ1.48p software (Wayne Rasband, National
Institutes of Health).
The average number of NMJ per genotype was obtained by counting the
junctions in 15 fields/mouse, randomly chosen, under a magnification of
20× objective. The analysis of the NMJ branches was performed according
to previous reports (Prakash et al., 1996).
RNA isolation and qRT-PCR
Total RNA, from skeletal muscle tissues, was extracted with Trizol reagent
and treated with DNase I (Ambion). DNA-free RNAwas reverse transcribed
using Promega cDNA Synthesis Kit according to the manufacturer’s
instructions.
qRT-PCR was performed with the SYBR-green master mix (Promega).
Data were normalized to the level ofGapdh and fold changewas determined
by using the 2−ΔΔCT method. All reactions were performed in triplicate.
The following primers were used: Myh7 (MyHC1), Fw 5′-AGTCCCA-
GGTCAACAAGCTG-3′ and Rv 5′-TTCCACCTAAAGGGCTGTTG-3′;
Myh2 (MyHC2A), Fw 5′-AGTCCCAGGTCAACAAGCTG-3′ and Rv 5′-
GCATGACCAAAGGTTTCACA-3′; Myh4 (MyHC2B), Fw 5′-AGTCC-
CAGGTCAACAAGCTG-3′ and Rv 5′-TTTCTCCTGTCACCTCTCAAC-
A-3′; Atrogin1, Fw 5′-AGCGCCATGGATACTGTACT-3′ and Rv 5′-
TCAGCTCCAACAGCCTTACT-3′; MuRF1, Fw 5′-TGCAAGGAACAC-
GAAGACGA-3′ and Rv 5′-TTTGCAAAGGGGCAACCTCA-3′; Igf1, Fw
5′-TGCTCTTCAGTTCGTGTG-3′ and Rv 5′-ACATCTCCAGTCTCCT-
CAG-3′; myogenin, Fw 5′-TACAGACGCCCACAATCTGC-3′ and Rv 5′-
AGTTGGGCATGGTTTCGTCT-3′; Acra7, Fw 5′-GCAGTGAGTGGA-
AGTTTGCG-3′ and Rv 5′-GTTTGGGGCTGACATGAGGA-3′; and
Gapdh, Fw 5′-GTGAAGGTCGGTGTGAACG-3′ and Rv 5′-ATTTGAT-
GTTAGTGGGGTCTCG-3′.
Western blotting
For western blot analysis, protein extraction from tibialis anterior of Atm+/+
and Atm−/− mice was performed in RIPA buffer (10 mM Tris-HCl pH 8.0,
140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1%
sodium deoxycholate, 0.1% SDS, 0.5 M DTT, 100 mM PMSF, 1 M
β-glycerophosphate, 0.5 M sodium orthovanadate and cocktail of protease
inhibitors). Tissue desegregation was achieved with a Ultra-Turrax T25
homogenizer (Janke & Kunkel). Equal amounts from each lysate were
separated in SDS polyacrylamide gel and transferred onto a nitrocellulose
membrane (Amersham). The membrane was blocked in 1× Tris-buffered
saline with 0.1% Tween 20/5% BSA for 1 h at room temperature and
then filters were incubated with primary antibodies at 4°C overnight. Blots
were washed extensively in 1× TBS-T and then incubated with the
specific horseradish peroxidase-conjugated secondary antibody (Santa
Cruz Biotechnology) for 1 h. The antibody binding was detected by
chemiluminescence with an ECL kit (1:10,000, Santa Cruz Biotechnology)
and images were recorded with the Syngene G-box system (Syngene
Bioimaging, Haryana, India). Densitometric analyses were performed by
ImageJ software (version 1.49). Antibodies used are listed below: mouse
anti-tubulin (1:10,000, Sigma, T5168), mouse anti-ubiquitin (1:500, Santa
Cruz Biotechnology, P4D1), rabbit anti-FoxO3a S253p (1:500, Cell
Signaling, 9466), mouse anti-FoxO3a (1:500, Santa Cruz Biotechnology,
48348), rabbit anti-Akt S473p (1:1000, Santa Cruz Biotechnology, 7985),
mouse anti-Akt (1:1000, Santa Cruz Biotechnology, 81434), rabbit anti-
GSK3β S9p (1:1000, Cell Signaling, 9336), mouse anti-GSK3β (1:1000,
Santa Cruz Biotechnology, 81462), rabbit anti-eIF4E S209p (1:1000,
Invitrogen, 44-528G), mouse anti-eIF4E (1:1000, Santa Cruz
Biotechnology, 271480), rabbit anti-4E-BP1 (1:1000, Cell Signaling,
9644), rabbit anti-LC3 (1:1000, MBL Int Corporation, PD014), mouse
anti-myosin, skeletal, slow (1:400, Sigma, M8421), mouse anti-myosin
heavy chain MyHC (1:5, from hybridoma bank, clone MF-20).
TEM
Tibialis anterior muscles were dissected from mice legs and immediately
fixed with a mixture of 2% (w/v) PFA and 2.5% (w/v) glutaraldehyde
(TAAB) in 0.1 M phosphate buffer (PB) pH 7.4 at 4°C for 24 h.
Subsequently, samples were post-fixed with 1% (w/v) OsO4 supplemented
with 1.5% (w/v) potassium ferrocyanide for 1 h on ice, replaced by 1% (w/v)
OsO4 in sodium cacodylate 0.1 M for an additional hour. Samples were then
dehydrated in series of ethanol and infiltrated with propylene oxide (Agar):
Durcupan (Agar) (1:1) followed by Durcupan embedding for 48 h. Ultrathin
sections were cut with an Ultracut S microtome (Leica), counter-stained with
lead citrate and observed with a Jeol 1010 transmission electron microscope.
Images were obtained using a Gatan MSC 791 CCD camera. The number of
sarcomeres/column were evaluated in 30 images/genotype. The long and
short axis, corresponding to I band distance and Z-line height, respectively,
were evaluated in central sarcomeres of the image. The number of
mitochondria were evaluated in 10 images/genotype. Dimensional analyses
were performed with ImageJ software (version 1.49).
Live imaging of muscle fibers labeled with MitoSOX Red
Tibialis anterior muscles from 2-month-old mice were dissected
longitudinally and labeled for 20 min at 37°C into HBSS buffer with
3.5 µM MitoSOX Red following (M36008 Invitrogen) manufacturer’s
instructions. Upon labeling, muscles were placed onto a 35 mm ø glass
bottom dishes (Ibidi, Martinsried, Germany) and kept at constant temperature
(37°C), humidity and CO2 (5%) by using a microscope incubation chamber.
Intact surfaces of tibialis were plated towards the detection lens (40× water)
for direct imaging with a Spinning Disk confocal Ultraview Vox (Perkin
Elmer), interfaced with Volocity 6.0 software (Cellular Imaging, Perkin
Elmer). A solid state laser, operating at 488 nm was used as an excitation
Fig. 7. NMJ abnormalities in Atm−/−muscles. (A) Representative maximum
projection of micrographs showing α-bungarotoxin (BTX; green) staining in
quadriceps muscles of Atm+/+ (A) and Atm−/− (B) mice. Scale bars: 20 μm.
(B) Morphometric analysis of quadriceps neuromuscular junctions. Analysis
was performed in n=4 mice/genotype. (C) Representative maximum projection
of photomicrographs showing α-bungarotoxin (green) and PGP 9.5 (red)
staining in quadriceps muscles of Atm+/+ and Atm−/−mice. Scale bars: 20 μm.
(D,E) qRT-PCR analysis for α7 neuronal nicotinic acetylcholine receptor
subunit (Acra7) and myogenin. Gapdh was used as housekeeping gene.
Data are mean±s.e.m. obtained from triplicates of n=3 mice/genotype.
*P<0.05; ***P<0.001.
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source and a band pass emission filter-cube of 587 (W125) for the acquisition.
Images were acquired using a Hamamatsu EMCCD camera; exposure time
and camera sensitivity were the same for all samples.
Three-dimensional image analysis was carried out with the help of Imaris
8.0 (Bitplane). For each fiber at least two fixed volumes of 170×170 pixel (in
xy) and 50 optical sections (in z) were measured as mean fluorescence
intensity values. For both Atm+/+ and Atm−/− mice a total of 20 random
fibers were analyzed.
Statistical analyses
All data are expressed as mean±s.e.m. Samples from Atm+/+ and Atm−/−
were analyzed with Student’s t-test, two tailed and one degree of freedom,
and plotted by using Graph Pad Prism version 6.0 (Graph pad software).
P<0.05 was considered significant for all tests.
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